Artal Group S.A. Adagene Inc. Transaction History

Artal Group S.A.

  • $214 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
BUY
$1.96 - $4.15 $39,200 - $83,000
20,000 Added 2.0%
1,020,000 $2.86 Million
Q2 2021

Aug 13, 2021
BUY
$11.8 - $17.87 $2.36 Million - $3.57 Million
200,000 Added 25.0%
1,000,000 $13.6 Million
Q1 2021

May 14, 2021
BUY
$17.0 - $29.99 $13.6 Million - $24 Million
800,000 New
800,000 $14.4 Million

Others Institutions Holding ADAG

# of Institutions
13
Shares Held
9.87M
Call Options Held
0
Put Options Held
0
View Full List

About Adagene Inc.

ADAG Quotes by TradingView
  • Ticker ADAG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,423,200
  • Market Cap $86.4M
  • Description
  • Adagene Inc., a clinical stage biopharmaceutical company, engages in the research, development, and production of monoclonal antibody drugs for cancers. The company's product candidates include ADG106, a human ligand-blocking agonistic anti-CD137 monoclonal antibodies (mAbs) that is in Phase 1b/2 clinical trials for the treatment advanced solid ...
More about ADAG
Track This Portfolio

Track Artal Group S.A. Portfolio

Follow Artal Group S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Artal Group S.A., based on Form 13F filings with the SEC.

News

Stay updated on Artal Group S.A. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email